These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25952330)

  • 21. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
    Stern MP; Williams K; Haffner SM
    Ann Intern Med; 2002 Apr; 136(8):575-81. PubMed ID: 11955025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prevalence of undiagnosed type 2 diabetes mellitus in consulting rooms of general practitioners].
    Vozár J;
    Vnitr Lek; 2001 Mar; 47(3):140-5. PubMed ID: 15635874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J; Stancáková A; Kuusisto J; Laakso M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3858-62. PubMed ID: 20463095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysglycemia risk score in Saudi Arabia: A tool to identify people at high future risk of developing type 2 diabetes.
    Bahijri S; Al-Raddadi R; Ajabnoor G; Jambi H; Al Ahmadi J; Borai A; Barengo NC; Tuomilehto J
    J Diabetes Investig; 2020 Jul; 11(4):844-855. PubMed ID: 31957345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasting plasma glucose levels predict steroid-induced abnormal glucose metabolism in patients with non-diabetic chronic kidney disease: a prospective cohort study.
    Yang X; Lin X; Lu T; Chen P; Wang X; Hou FF
    Am J Nephrol; 2015; 41(2):107-15. PubMed ID: 25766034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
    Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-laboratory-based risk assessment model for case detection of diabetes mellitus and pre-diabetes in primary care.
    Dong W; Tse TYE; Mak LI; Wong CKH; Wan YFE; Tang HME; Chin WY; Bedford LE; Yu YTE; Ko WKW; Chao VKD; Tan CBK; Lam LKC
    J Diabetes Investig; 2022 Aug; 13(8):1374-1386. PubMed ID: 35293149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivation and validation of diabetes risk score for urban Asian Indians.
    Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
    Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new non-invasive technology to screen for dysglycaemia including diabetes.
    Ramachandran A; Moses A; Shetty S; Thirupurasundari CJ; Seeli AC; Snehalatha C; Singvi S; Deslypere JP
    Diabetes Res Clin Pract; 2010 Jun; 88(3):302-6. PubMed ID: 20188429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based screening of type 2 diabetes in high-risk population of Yasuj, Iran.
    Safari M; Yazdanpanah B; Yazdanpanah B; Mobasheri A
    J Health Popul Nutr; 2014 Dec; 32(4):677-86. PubMed ID: 25895201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
    Fu SN; Luk W; Wong CK; Cheung KL
    J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population.
    Doi Y; Kubo M; Yonemoto K; Ninomiya T; Iwase M; Arima H; Hata J; Tanizaki Y; Iida M; Kiyohara Y
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3425-9. PubMed ID: 18559920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Chinese risk score model for identifying postprandial hyperglycemia without oral glucose tolerance test.
    Fu Q; Sun M; Tang W; Wang Z; Cao M; Zhu Z; Lu L; Bi Y; Ning G; Yang T
    Diabetes Metab Res Rev; 2014 May; 30(4):284-90. PubMed ID: 24154991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.
    Fonville S; den Hertog HM; Zandbergen AA; Koudstaal PJ; Lingsma HF
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1669-75. PubMed ID: 24725814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men.
    Almdal T; Scharling H; Jensen JS; Vestergaard H
    Eur J Intern Med; 2008 Jan; 19(1):40-5. PubMed ID: 18206600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.